Overview
- 29 inspections across 27 sites are on record.
- 84 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-11.
At a glance
Inspections
29
Sites
27
Observations
84
Career since
Sep 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Trifluent Pharma LLC | 11 Jun 2026 | Human Drugs | View 483 → |
| SnugZ USA, Inc. | 1 May 2026 | Human Drugs | View 483 → |
| Becton Dickinson Infusion Therapy Systems, Inc. | 26 Mar 2026 | Human Drugs | View 483 → |
| DPT Laboratories Ltd | 10 Feb 2026 | Human Drugs | View 483 → |
| EUROSIREL S.P.A | 26 Sep 2025 | Human Drugs | View 483 → |
Sites inspected
Trifluent Pharma LLCSan Antonio, United States1 insp.
SnugZ USA, Inc.West Jordan, United States1 insp.
Becton Dickinson Infusion Therapy Systems, Inc.Sandy, United States1 insp.
DPT Laboratories LtdSan Antonio, United States1 insp.
EUROSIREL S.P.ACusago, Italy1 insp.
Co-investigators
Investigators who share inspections with this person.
Margaret M Annes7 shared
Kevin T Nguyen4 shared
Patty P Kaewussdangkul3 shared
Demario L Walls1 shared
Milton J De Jesus Tavarez1 shared
Clinton J Lott1 shared
Jessica M Simpson1 shared
Charles D Brown1 shared
Michelle A Krayer1 shared
Kenitra D Hewitt1 shared
Full investigator report
Get the verbatim findings behind Shanna N Purdy's 84 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site